Doctors step into virtual exam room to test genetic dosing decisions

NCT ID NCT02108041

Completed Knowledge-focused Sponsor: National Human Genome Research Institute (NHGRI) Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 7 times

Summary

This study looked at how doctors make decisions about dosing the blood thinner warfarin based on a patient's genetic background. Researchers used virtual reality to simulate patient visits with different racial and socioeconomic backgrounds. 196 internal medicine residents participated in the 60-minute session. The goal was to understand how personalized medicine is used in practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help train doctors to better use genetic testing for personalized drug dosing.
What could go wrong: This is a small, completed observational study with healthy doctors in a virtual setting, not a real patient trial. Results may not reflect actual clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CLOTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thrombotic disease venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CLOTS DEEP VEIN THROMBOSIS

Contacts and locations

Locations

Columbia University

New York, New York, 10032-3784, United States
Harvard School of Public Health

Boston, Massachusetts, 02115, United States
Johns Hopkins School of Medicine

Baltimore, Maryland, 21205, United States
Michigan State University

Flint, Michigan, United States
University of Oregon

Eugene, Oregon, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.